Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes

Biotechnology and Bioengineering

Volumn 50, Issue 4, 1996, Pages 422-429

  Mooney, David J ^a,b   Kaufmann, Peter Matthias ^b   Sano, Kaoru ^b   Schwendeman, Steven P ^a   Majahod, Karen ^a   Schloo, B ^c   Vacanti, Joseph P ^b   Langer, Robert ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c DEBORAH HEART AND LUNG CENTER   (United States)

Author keywords

drug delivery; hepatocytes; polylactic acid; transplantation

Indexed keywords

COPOLYMERS; DISEASES; DRUG THERAPY; GROWTH KINETICS; IMPLANTS (SURGICAL); ORGANIC ACIDS; TRANSPLANTATION (SURGICAL);

DRUG DELIVERY; ENGRAFTMENT; EPIDERMAL GROWTH; HEPATOCYTES; MICROSPHERES; POLYLACTIC ACID;

CELLS;

CELL DNA; EPIDERMAL GROWTH FACTOR; MICROSPHERE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA SYNTHESIS; GRAFT SURVIVAL; LIVER TRANSPLANTATION; NONHUMAN; RAT;

EID: 15844412757     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N     Document Type: Article

References (25)

1. American Liver Foundation. 1988. Vital Statistics of the United States, vol. 2(A).
2. Annual Report of the U.S. Scientific Registry for Organ transplantation and the Organ Procurement and Transplant Network. 1990, UNOS, p. 19. Richmond, VA. and the Division of Organ Transplantation, Health Resources and Services Administration, PE59, Bethesda, MD.
3. Asonuma, K., Gilbert, J C., Stein, J. E., Takeda, T., Vacanti, J. P. 1992. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J. Pediat. Surg. 27; 298-301.
4. Barrera, D. A., Zylstra, E., Lansbury, P. T., Langer, R. 1993. Synthesis and RGD peptide modification of a new biodegradable copolymer: Poly(lactic acid-co-lysine), J. Am. Chem. Soc, 115: 11010-11011.
5. Brown, L., Siemer, L., Munoz, C., Langer, R. 1986. Controlled release of insulin from polymer matrices. Diabetes 35: 684-691.
6. Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., Langer, R. 1991. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8: 713-720.
7. Fausto, N. 1991. Growth factors in liver development, regeneration, and carcinogenesis. Prog. Growth Factor Res. 3: 219-234.
8. Hansen, L. K., Vacanti, J. P. 1993. Hepatocytes transplantation using artificial biodegradable polymers, pp. 96-106. In: M. A. Hoffman (ed.), Current controversies in biliary atresia. R. G. Landes, Austin, TX.
9. Higgins, G. M., Anderson, R. M. 1931. Experimental pathology of the liver. Arch. Pathol. 12: 186-201.
10. Jaffe, V., Darby, H., Bishop, A., Hodgson, H. J. 1991. The growth of liver cells in the pancreas after intrasplenic implantation: The effects of portal perfusion. Int. J. Exp. Pathol. 72: 289-299.
11. Kaufmann, P. M., Sano, K., Uyama, S., Vacanti, J. P. 1994. Heterotopic hepatocyte transplantation using three-dimensional polymers. Evaluation of the stimulatory effects by portacaval shunt or islet cell co-transplantation. Transplant. Proc. 26: 3343-3345.
12. Langer, R. 1990. New methods of drug delivery. Science 249: 1527-1533.
13. Mooney, D., Hansen, L., Vacanti, J., Langer, R., Farmer, S., Ingber, D. 1992. Switching from differentiation to growth in hepatocytes: Control by extracellular matrix. J. Cell Physiol. 151: 497-505.
14. Mooney, D. J., Park, S., Kaufmann, P. M., Sano, K., McNamara, K., Vacanti, J. P., Langer, R. 1995. Biodegradable sponges for hepatocyte transplantation. J. Biomed. Mater. Res. 29: 959-966.
15. Mooney, D. J., Cima, L., Langer, R., Johnson, L. B., Hansen, L. K., Ingber, D. E., Vacanti, J. P. 1992. Principles of tissue engineering and reconstruction using polymer-cell constructs. Proc. Mater. Res. Soc. 252: 345-352.
16. Mooney, D. J. 1992. pp. 45-47. Ph.D. thesis, Massachusetts Institute of Technology, Cambridge, MA, USA.
17. Murray, J. B., Brown, L., Langer, R., Klagsburn, M. 1983. A micro sustained release system for epidermal growth factor. In Vitro 10: 743-748.
18. Nakamura, T., Teramoto, H., Ichihar, A. 1986. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culture. Proc. Natl. Acad. Sci. USA 83: 6489-6493.
19. Ricordi, C., Lacy, P. E., Gallery, M. P., Park, P. W., Flye, M. W. 1989. Trophic factors from pancreatic islets in combined hepatocyte-islet altografts enhance hepatocellular survival. Surgery 105: 218-223.
20. Shiota, G., Wang, T. C., Nakamura, T., Schmidt, E. V. 1994. Hepatocyte growth factor in transgenic mice: Effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 19: 962-972.
21. Sluzky, V., Tamada, J. A., Klibanov, A. M., Langer, R. 1991. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. 88: 9377-9381.
22. Starzl, T. E., Demetris, A. J., Van Thiel, D. 1989. Chronic liver failure: Orthotopic liver transplantation. N. Engl. J. Med 321: 1014-1022.
23. Uyama, S., Kaufmann, P. M., Takeda, T., Vacantl, J. P. 1993. Delivery of a whole liver equivalent hepatic mass using polymer devices and hepatotrophic Stimulation. Transplantation 55: 932-935.
24. Vacanti, J. P., Morse, M. A., Saltzman, W. M., Domb, A. J., PerezAtayde, A., Langer, R. 1988. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J. Pediat. Surg. 23: 3-9.
25. Wilson, J. M., Grossman, M., Raper, S. E., Baker, J. R., Newton, R. S., Thoene, J. G. 1992. Ex vivo gene therapy of familial hypercholesteremia. Human Gene Ther. 3: 179-222.